Literature DB >> 14648657

Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.

Philippe O Van Trappen1, Dawn Steele, David G Lowe, Suhail Baithun, Nigel Beasley, Wilko Thiele, Herbert Weich, Jaya Krishnan, John H Shepherd, Michael S Pepper, David G Jackson, Jonathan P Sleeman, Ian J Jacobs.   

Abstract

Cervical carcinogenesis has well-defined stages of disease progression including three grades of pre-invasive lesions--cervical intraepithelial neoplasia grades 1-3 (CIN 1-3)--and invasive cervical cancer. However, the biological properties of CIN lesions prone to develop invasive disease are not well defined. Recent observations suggest that early invasive disease spreads to regional lymph nodes in several tumour types and that growth factors (VEGF-C and VEGF-D) involved in new lymphatic vessel formation may play a crucial role in this process. The present study has assessed the expression of VEGF-C and VEGF-D, and their receptor VEGFR-3, in 152 cervical lesions (33 CIN 1, 33 CIN 2, 37 CIN 3, and 49 squamous cell carcinomas) to determine whether expression of lymphangiogenic factors occurs prior to invasion. The presence of lymphatic vessels was determined using LYVE-1 and podoplanin staining, as well as double immunostaining for LYVE-1/CD34 and podoplanin/CD34. In situ hybridization was performed to determine VEGFR-3 mRNA expression. A significant positive correlation was found between VEGF-C, VEGF-D, and VEGFR-3 expression through the different stages of cervical carcinogenesis. Significant differences in protein expression for VEGF-C, VEGF-D, and VEGFR-3 were found between CIN 1-2 and CIN 3 (p<0.001 for all), but not between CIN 3 and cervical cancer. More than 50% of the CIN 3 lesions showed moderate to strong staining for VEGF-C and VEGF-D, whereas most of the early pre-cancerous lesions (CIN 1 and 2) were negative. In cervical cancer, similar observations to those in CIN 3 were found. VEGFR-3 mRNA expression was found in the cytoplasm of epithelial neoplastic cells and VEGFR3 protein expression was found in more than 50% of CIN 3 lesions and cervical cancers, compared with 15% in CIN 1 and 2. These findings suggest an autocrine growth stimulation pattern via VEGFR-3. Adjacent CIN 3 was present in nine cervical cancers and displayed strong expression for VEGF-C, VEGF-D, and VEGFR-3. These results suggest that in cervical carcinogenesis a switch to the lymphangiogenic phenotype may occur at the stage of CIN 3. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648657     DOI: 10.1002/path.1467

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  39 in total

1.  Synthesis of ribozyme against vascular endothelial growth factor165 and its biological activity in vitro.

Authors:  Zhong-Ping Gu; Yun-Jie Wang; Yu Wu; Jin-Ge Li; Nong-An Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.

Authors:  M Branca; C Giorgi; D Santini; L Di Bonito; M Ciotti; A Benedetto; P Paba; S Costa; D Bonifacio; P Di Bonito; L Accardi; C Favalli; K Syrjänen
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 3.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Cigarette smoke stimulates VEGF-C expression in cervical intraepithelial neoplasia (CIN) 1 and 2 lesions.

Authors:  Morihiko Inamine; Yutaka Nagai; Akira Mitsuhashi; Satoru Nagase; Nobuo Yaegashi; Hiroyuki Yoshikawa; Yoichi Aoki
Journal:  Int J Clin Oncol       Date:  2011-09-27       Impact factor: 3.402

5.  Effects of endostatin on expression of vascular endothelial growth factor and its receptors and neovascularization in colonic carcinoma implanted in nude mice.

Authors:  Yun-He Jia; Xin-Shu Dong; Xi-Shan Wang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 6.  Potential therapeutic strategies for lymphatic metastasis.

Authors:  Bernadette M M Zwaans; Diane R Bielenberg
Journal:  Microvasc Res       Date:  2007-09-19       Impact factor: 3.514

7.  Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.

Authors:  Mian He; Yang Cheng; Wen Li; Qiongshan Liu; Junxiu Liu; Jinghe Huang; Xiaodong Fu
Journal:  BMC Cancer       Date:  2010-04-29       Impact factor: 4.430

8.  Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.

Authors:  Tatsuya Tanaka; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Takeyasu Katada; Midori Shiozaki; Yasuhiro Naganawa; Yoshitaka Fujii; Hiromitsu Takeyama
Journal:  J Exp Clin Cancer Res       Date:  2010-06-28

9.  STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer.

Authors:  Yujuan Chen; Jing Wang; Xiaodong Wang; Xuejuan Liu; Hongjiang Li; Qing Lv; Jingqiang Zhu; Bing Wei; Ying Tang
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

10.  The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.

Authors:  Hao Yu; Shiqian Zhang; Renhua Zhang; Linlin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.